Literature DB >> 9881267

[Effect of smoking on the long-term course of ulcerative colitis].

M Mokbel1, F Carbonnel, L Beaugerie, J P Gendre, J Cosnes.   

Abstract

OBJECTIVE: To evaluate the effects of smoking on the long term clinical course in patients with ulcerative colitis.
METHODS: The medical charts of 556 patients with ulcerative colitis were reviewed retrospectively. Patients were classified as smokers (n = 85) or nonsmokers (n = 471) according to their smoking status during the course of the disease. Extent of colonic lesions, complications, medical requirements, and actuarial rate of colectomy were compared in smokers and nonsmokers.
RESULTS: Mean follow-up (+/- SD) was longer in smokers than in nonsmokers (116 +/- 107 mo, vs 87 +/- 94 mo.). Less smokers than nonsmokers required oral steroids (52 vs 63%, P = 0.05). No difference between the groups was observed regarding the use of salicylates, the need for intravenous steroids, for immunosuppressive drugs, for colectomy, and the occurrence of complications. The actuarial rate of colectomy was less in smokers than in nonsmokers (32 +/- 12% and 42 +/- 6% at 10 years respectively. P = 0.04). Initial and cumulative extent of the disease process did not differ between the groups. However, in the subgroup of patients with limited disease at onset, development of pancolitis was less frequent in smokers than in nonsmokers (14 and 26%, respectively, P = 0.04).
CONCLUSION: The lesser need for oral steroids and the lower actuarial rate of colectomy in smokers suggest that ulcerative colitis in smokers is characterized by a less severe clinical presentation and a better long term prognosis than in nonsmokers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9881267

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  14 in total

1.  Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis.

Authors:  H S Odes; A Fich; S Reif; A Halak; A Lavy; D Keter; R Eliakim; J Paz; E Broide; Y Niv; Y Ron; Y Villa; N Arber; T Gilat
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

Review 2.  Management of Ulcerative Colitis in the Elderly.

Authors:  Manish P Shrestha; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

Review 3.  Smoking in inflammatory bowel diseases: good, bad or ugly?

Authors:  Peter Laszlo Lakatos; Tamas Szamosi; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

Review 4.  Ulcerative colitis in smokers, non-smokers and ex-smokers.

Authors:  Guillermo Bastida; Belén Beltrán
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 5.  Impact of environmental and dietary factors on the course of inflammatory bowel disease.

Authors:  Eduard Cabré; Eugeni Domènech
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

6.  Side-stream smoking reduces intestinal inflammation and increases expression of tight junction proteins.

Authors:  Hui Wang; Jun-Xing Zhao; Nan Hu; Jun Ren; Min Du; Mei-Jun Zhu
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

7.  Effects of appendicectomy on the course of ulcerative colitis.

Authors:  J Cosnes; F Carbonnel; L Beaugerie; A Blain; D Reijasse; J-P Gendre
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

8.  Genetic predictors of medically refractory ulcerative colitis.

Authors:  Talin Haritunians; Kent D Taylor; Stephan R Targan; Marla Dubinsky; Andrew Ippoliti; Soonil Kwon; Xiuqing Guo; Gil Y Melmed; Dror Berel; Emebet Mengesha; Bruce M Psaty; Nicole L Glazer; Eric A Vasiliauskas; Jerome I Rotter; Phillip R Fleshner; Dermot P B McGovern
Journal:  Inflamm Bowel Dis       Date:  2010-11       Impact factor: 5.325

Review 9.  Environmental risk factors for inflammatory bowel diseases: Evidence based literature review.

Authors:  Ayokunle T Abegunde; Bashir H Muhammad; Owais Bhatti; Tauseef Ali
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

10.  Novel insights on the effect of nicotine in a murine colitis model.

Authors:  Shakir D AlSharari; Hamid I Akbarali; Rehab A Abdullah; Omer Shahab; Wimolnut Auttachoat; Gabriela A Ferreira; Kimber L White; Aron H Lichtman; Guy A Cabral; M Imad Damaj
Journal:  J Pharmacol Exp Ther       Date:  2012-10-31       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.